Bullous pemphigoid successfully treated with dupilumab

被引：0

作者：

Martinez, Daniela de Abreu e Silva ^{[1
]}

Periquito, Amanda de Freitas Sampaio ^{[2
]}

Roa, Graciela Galva ^{[2
]}

Lupi, Joao Pedro ^{[3
]}

Treu, Curt Mafra ^{[2
]}

Lupi, Omar ^{[2
]}

机构：

[1] Univ Fed Rio De Janeiro, Hosp Univ Clementino Fraga Filho, Dept Immunol, Rio De Janeiro, RJ, Brazil

[2] Policlin Geral Rio De Janeiro, Dept Dermatol, Rio De Janeiro, RJ, Brazil

[3] Univ Estado Rio De Janeiro, Hosp Univ Pedro Ernesto, Dept Med, Rio De Janeiro, RJ, Brazil

来源：

ANAIS BRASILEIROS DE DERMATOLOGIA | 2024年 / 99卷 / 05期

关键词：

D O I：

10.1016/j.abd.2023.08.017

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：778 / 780

页数：3

共 10 条

[1] Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV) [J].

Borradori, L. ;

Van Beek, N. ;

Feliciani, C. ;

Tedbirt, B. ;

Antiga, E. ;

Bergman, R. ;

Boeckle, B. C. ;

Caproni, M. ;

Caux, F. ;

Chandran, N. S. ;

Cianchini, G. ;

Daneshpazhooh, M. ;

De, D. ;

Didona, D. ;

Di Zenzo, G. M. ;

Dmochowski, M. ;

Drenovska, K. ;

Ehrchen, J. ;

Goebeler, M. ;

Groves, R. ;

Guenther, C. ;

Horvath, B. ;

Hertl, M. ;

Hofmann, S. ;

Ioannides, D. ;

Itzlinger-Monshi, B. ;

Jedlickova, J. ;

Kowalewski, C. ;

Kridin, K. ;

Lim, Y. L. ;

Marinovic, B. ;

Marzano, A. ;

Mascaro, J. -M. ;

Meijer, J. M. ;

Murrell, D. ;

Patsatsi, K. ;

Pincelli, C. ;

Prost, C. ;

Rappersberger, K. ;

Sardy, M. ;

Setterfield, J. ;

Shahid, M. ;

Sprecher, E. ;

Tasanen, K. ;

Uzun, S. ;

Vassileva, S. ;

Vestergaard, K. ;

Vorobyev, A. ;

Vujic, I. ;

Wang, G. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (10) :1689-1704

[2] Nine cases of refractory bullous pemphigoid treated with dupilumab and literature review [J].

Liang, Junqin ;

Abulikemu, Kailibinuer ;

Hu, Fengxia ;

Zhao, Juan ;

Qiu, Yun ;

Wang, Qian ;

Sang, Yingbing ;

Hong, Yongzhen ;

Kang, Xiaojing .

INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 116

[3] Dupilumab: A Review of Present Indications and Off-Label Uses [J].

Munoz-Bellido, F. J. ;

Moreno, E. ;

Davila, I .

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2022, 32 (02) :97-115

[4] Use of Dupilumab in Bullous Pemphigoid: Where Are We Now? [J].

Russo, Roberto ;

Capurro, Niccolo ;

Cozzani, Emanuele ;

Parodi, Aurora .

JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)

[5]

Saleh M, 2021, Dermatol Online J, V27, p13030/qt0dv3f9h6, DOI [10.5070/D3274053155, DOI 10.5070/D3274053155]

[6] Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology [J].

Santi, Claudia Giuli ;

Grippe, Alexandre Carlos ;

Roselino, Ana Maria ;

Mello, Danielle Santana ;

Gordilho, Juliana Olivieri ;

de Marsillac, Paula Figueiredo ;

Porro, Adriana Maria .

ANAIS BRASILEIROS DE DERMATOLOGIA, 2019, 94 (02) :S33-S47

[7] Bullous pemphigoid: The role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy [J].

Zhang, Luyao ;

Chen, Zihua ;

Wang, Lanting ;

Luo, Xiaoqun .

FRONTIERS IN IMMUNOLOGY, 2023, 14

[8] Dupilumab as a novel therapy for bullous pemphigoid [J].

Zhang, Xuetong ;

Man, Xiaoyong ;

Tang, Zhuangli ;

Dai, Ru ;

Shen, Ying .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (04) :E263-E266

[9] Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid [J].

Zhang, Yihua ;

Xu, Qiuyun ;

Chen, Lihong ;

Chen, Jiawen ;

Zhang, Jing ;

Zou, Ying ;

Gong, Ting ;

Ji, Chao .

FRONTIERS IN IMMUNOLOGY, 2021, 12

[10]

Zhou Albert E, 2022, JAAD Case Rep, V29, P149, DOI 10.1016/j.jdcr.2022.09.017

← 1 →